PMC:7445716 / 44802-45039 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T237","span":{"begin":12,"end":24},"obj":"Body_part"},{"id":"T238","span":{"begin":201,"end":213},"obj":"Body_part"}],"attributes":[{"id":"A237","pred":"fma_id","subj":"T237","obj":"http://purl.org/sig/ont/fma/fma50868"},{"id":"A238","pred":"fma_id","subj":"T238","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T124","span":{"begin":12,"end":24},"obj":"Body_part"},{"id":"T125","span":{"begin":19,"end":24},"obj":"Body_part"}],"attributes":[{"id":"A124","pred":"uberon_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/UBERON_0001647"},{"id":"A125","pred":"uberon_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T286","span":{"begin":19,"end":24},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T262","span":{"begin":69,"end":81},"obj":"Chemical"},{"id":"T263","span":{"begin":86,"end":97},"obj":"Chemical"},{"id":"T264","span":{"begin":184,"end":186},"obj":"Chemical"},{"id":"T265","span":{"begin":201,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A262","pred":"chebi_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A263","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_29007"},{"id":"A264","pred":"chebi_id","subj":"T264","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A265","pred":"chebi_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}

{"project":"LitCovid-PubTator","denotations":[{"id":"890","span":{"begin":119,"end":134},"obj":"Disease"}],"attributes":[{"id":"A890","pred":"tao:has_database_id","subj":"890","obj":"MESH:D018908"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T652","span":{"begin":120,"end":135},"obj":"Phenotype"}],"attributes":[{"id":"A652","pred":"hp_id","subj":"T652","obj":"http://purl.obolibrary.org/obo/HP_0030319"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T456","span":{"begin":12,"end":24},"obj":"UBERON:0001647"},{"id":"T457","span":{"begin":69,"end":81},"obj":"DG_6"},{"id":"T458","span":{"begin":120,"end":126},"obj":"UBERON:0001456"},{"id":"T459","span":{"begin":201,"end":213},"obj":"CHEBI:16856;CHEBI:16856"},{"id":"T460","span":{"begin":214,"end":234},"obj":"GO:0042571"}],"text":"ntracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia\nChan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased to"}